8 completed, 4 terminated, 1 not yet recruiting, 1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow PeriPharm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Breast Neoplasms (1) · Caregiver Burden (1) · Dermatitis, Atopic (1) · Diabetes Mellitus, Type 1 (1) · Eczema (1) · Hidradenitis Suppurativa (1) · Lupus Erythematosus, Systemic (1) · Migraine Disorders (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1) · Ovarian Neoplasms (1) · Sleep Initiation and Maintenance Disorders (1)
Observation (2) · Triamcinolone Acetonide (1) · daridorexant (1)
Canada (13)
Jean Lachaine, PhD (4) · Jason Agulnik, MD (2) · Victor Cohen, MD (2) · Jean Lachaine (1)